Lbt Innovations Share Price and Company Fundamentals
Last traded: Today at 2:25 AM
LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. The company offers MicroStreak, an automated culture-plate streaking and inoculation system; and Automated Plate Assessment System, a platform technology that automates culture-plate screening and interpretation. It also develops Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds; and devices that can detect biofilms in the presence of mammalian tissue. The company was incorporated in 2004 and is headquartered in Adelaide, Australia.
|Primary activities||Development of technology for use in automation of microbiology laboratory processing.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||16 Anster Street Adelaide SA 5000 Australia|
|Phone / Fax||61 8 8227 1555 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Lbt Innovations does not pay dividends.
As of Jan 2022, following are the company executives and directors listed on Lbt Innovations.
|Mr. Brenton John Barnes||CEO, MD & Director||380k|
|Mr. Raymond Robert Ridge B.A., BA (Acc), C.A., CA, GIA (cert)||CFO & Company Sec.||179k|
|Mr. Peter M. Bradley||VP of Global Bus. Devel.||223k|
|Mr. Pablo Cesar Solis Madrigal||Director of Technology Devel.|
|Dr. Steven Giglio||Scientific Director|
|Mr. Jack Brown||Corp. Devel. Director|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Lbt Innovations is and its enterprise value is .
The LBT's stocks Beta value is 0.46 making it 54% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Lbt Innovations (LBT)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Lbt Innovations (ASX:LBT) Frequently Asked Questions
1. What is Lbt Innovations's Stock Symbol?
Lbt Innovations trades on ASX under the ticker symbol "LBT".
2. What is Lbt Innovations's stock price today?
One share of LBT stock can currently be purchased for approximately $0.097.
3. How can I contact Lbt Innovations?
Lbt Innovations's mailing address is 16 Anster Street Adelaide SA 5000 Australia. The company can be reached via phone at 61 8 8227 1555.
4. What is Lbt Innovations's official website?
The official website of Lbt Innovations is https://www.lbtinnovations.com.
5. Which share registry manages Lbt Innovations's stock?
Lbt Innovations's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.